Search PubMed⌕ Search

PubMed · 9312706

[New developments in covering post-traumatic soft tissue defects].

Abstract

Posttraumatic soft tissue defects, alone or combined with fractures, still present challenging problems of diagnosis and choice of treatment, unless they are suitable for primary closure. The reasons are to be found in their varied ethiology and degree of severity. In order to apply the optimal therapy to the patient, a complete understanding of the defect present, an optimal timing of surgery and a full knowledge of all treatment options are mandatory. The treatment concept presented is based on our personal experience between 1981 and 1995 after more than 5000 skin transplantations, some 3000 local tissue transfer, over 200 distant flap transfers and more than 1200 free microvascular tissue transfer to all regions of the body. New therapy concepts do not entirely replace the elder ones, but are integrated into the treatment schedule.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A Berger, R Hierner. 1997. [New developments in covering post-traumatic soft tissue defects].. https://doi.org/10.1007/s001320050114

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

[Fibromyalgia. Diagnostics--disease approach--therapy].

Fibromyalgia is a complex of symptoms predominantly affecting females and consisting of widespread pain. Etiology and pathogenesis are not sufficiently known yet, however, there is the assumption that fibromyalgia is looked at as being an illness with biological, psychological, and social aspects. Therefore, the treatment of fibromyalgia calls for a multimodal therapy approach. The importance of fibromyalgia has been recognized within the German health system by creating the new ICD code M79.70 and by assigning fibromyalgia its own rheumatologic DRG (I79Z). In future research of fibromyalgia special attention needs to be placed upon gender-specific problems.

Combined Modality Therapy↗

Lack of survival benefit of post-operative radiation therapy in prostate cancer patients with positive lymph nodes.

Randomized data from SWOG 8794 and EORTC 22911 confirm the benefit of post-operative radiation therapy (RT) for selected patients with pT3 prostate cancer (CaP) after radical prostatectomy (RP). However, data regarding the potential benefit of RT for patients post-RP with positive lymph node (+LN) involvement are limited. We analyzed the Surveillance Epidemiology End Results (SEER) registry for population-based data on efficacy of post-operative RT for +LN patients after RP. As LN data have only been captured by SEER since 1988, we analyzed data for 1988-1992, with specific attention to 10-year relative survival (defined as observed survival divided by the survival of a gender-, age- and race-matched population cohort without disease). Specifically analyzed were data for 1921 patients with nonmetastatic prostate cancer who underwent surgery alone, or surgery followed by RT, and who had +LNs documented. SEER does not code the interval between surgery and RT, so the ratio of patients receiving salvage versus adjuvant therapy is unknown. Using follow-up data through 2002, post-diagnosis survival was examined by number of +LNs. There was no significant relative survival benefit for +LN patients receiving post-operative RT (chi(2)P=0.270). These data do not support routine use of post-operative RT for patients with +LNs in the surgical specimen.

Combined Modality Therapy↗